About Ax-S Pharma

Ax-S Pharma LLC was created to provide clear, constructive guidance about pre-market access to medicines in serious diseases.  Since 2013 the company has advised commercial, government, and non-profit clients on the regulation and best-practices of FDA-authorized Expanded Access, with an emphasis on scalability and data generation. In 2017, Ax-S Pharma launched the inaugural Expanded Access Summit ®, which has taken place annually in Cambridge MA and Washington DC and has become the largest in-person forum on pre-market access to medicines, worldwide. The 2020-2021 Ax-S Thursdays e-Conference Series on Expanding Access to New Medicines is a new 3- month installation of weekly LiveCasts, partnering, and on-demand video modules.  Its scope has widened to include a range of innovations that integrate clinical research into modern healthcare delivery. As the leading provider of education and advisory in its topic, Ax-S Pharma remains uninfluenced by third-party affiliations.  All programming is guided by its mission of making meaningfully-sized pre-market medicines access easier for stakeholders to undertake, for all patients in need, in all serious unsolved health conditions, in all parts of the world.
Jess Rabourn, CFA Executive Producer, Expanded Access Summit | CEO, WideTrial, Inc.

Ax-S Pharma founder, Jess Rabourn CFA